VolitionRx Demonstrates NuQ® Blood Test Detects 95% of Pancreatic Cancers in Second Preliminary Study - Introduction to VolitionRx Nucleosomics� technology: Revolutionizing cancer diagnosis
MPEG•Episode home
Manage episode 153974432 series 1108677
Content provided by webcast@multivu.com. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by webcast@multivu.com or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
VolitionRx�s Nucleosomics� diagnostic platform detects epigenetic changes to fragments of chromosomes, called nucleosomes, that circulate in the blood of cancer patients. Credit: VolitionRx.
…
continue reading
154 episodes